YEAR IN REVIEW
METABOLIC DISORDERS AND COMPLICATIONS (MeDiC) PROGRAM
Understanding the health impact of inactivity for the benefit of older adults—and astronauts!
Directed by Dr. José A. Morais at the Centre for Innovative Medicine, a study was launched this year using bedrest as an analog to microgravity to provide data for eight Canadian research projects. Funding: CIHR.
Strategies to reduce breast cancer growth and related skeletal lesions
With international partners, Dr. Shafaat Rabbani’s team presented a novel approach to target both tumour growth and the skeletal lesions caused by breast cancer-induced bone disease. First author: doctoral student Niaz Mahmoud, Bone Research. Funding: CIHR.
Vaccine efficacy and hemodialysis
Dr. Rita Suri showed that most dialysis patients do not develop adequate antibodies with one dose of SARS-CoV-2 vaccine. Her study in CMAJ advised that patients receiving hemodialysis be prioritized for a second BNT162b2 [Pfizer] dose at the recommended three-week interval.
Selected news links
- Understanding the health impact of inactivity for the benefit of older adults and astronauts
- Study identifies strategies to reduce breast cancer growth and related skeletal lesions
- New research looks at vaccination efficacy and hemodialysis
- How does the hunger-suppressing hormone leptin cross the blood-brain barrier?
- INESSS honours McGill team for contributions to pandemic hospital projections
- Inappropriate prescriptions sending hospitalized seniors back to the ER
- More MeDiC Program news